Office Surgery Standards of Practice
HB 309, titled the “Office Surgery Standards of Practice” and cited as “Hillary’s Law,” would tighten Florida’s regulation of office-based surgeries for both allopathic and osteopathic physicians. The bill requires registered office surgery settings to undergo at least annual inspections by the Department of Health, with patient-record review, and adds a separate requirement that offices be inspected by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) and meet JCAHO ambulatory surgery center standards. Offices that refuse inspection would have their registration immediately suspended for at least 14 days and could not reopen until the department completes an inspection and authorizes reopening.
The bill also narrows what may be performed in an office surgery setting and imposes detailed practice rules. It prohibits office surgeries that involve major blood loss, major intracranial/intrathoracic/abdominal/joint replacement procedures, major blood vessels, or emergencies/life-threatening conditions. For gluteal fat grafting, it adds specific safeguards: an in-person exam the day before, direct physician performance of fat extraction and injection, limits on injection depth, mandatory ultrasound or equivalent guidance, and a one-physician-to-one-patient ratio throughout the procedure. It also bars physicians from operating on immediate family members, restricts changes to informed consent after signing or sedation, requires licensed/certified staff with ACLS certification, mandates certain emergency equipment and anesthesia oversight, and requires adverse-incident reporting and evidence preservation when hospitalization or local-anesthetic incidents occur.
HB 309 would amend both section 458.328 and section 459.0138 of the Florida Statutes, meaning the same office-surgery framework would apply to physicians licensed under chapters 458 and 459. It would also create an oversight committee within the Department of Health to monitor violations and report them to the department. In addition, the bill requires physicians performing office surgeries to maintain at least $1 million in malpractice insurance or equivalent financial responsibility. The act is set to take effect July 1, 2025.
Because there are no committee transcripts or recorded votes provided, there is no documented floor or committee sentiment in the available materials. Based on the bill text alone, the measure appears strongly patient-safety oriented and regulatory in nature, with an emphasis on preventing complications in office-based cosmetic and invasive procedures, especially gluteal fat grafting. The overall tone of the proposal is precautionary and enforcement-focused rather than permissive.
The main points of contention likely center on the bill’s cost and compliance burden for physicians and office-based surgical practices, including annual inspections, JCAHO accreditation, staffing and equipment requirements, and the $1 million insurance mandate. Another likely issue is the bill’s strict limitations on gluteal fat grafting and the prohibition on certain office procedures, which could be viewed by some practitioners as overly restrictive while others would see them as necessary safety protections. No opposing arguments are documented in the provided context, but the structure of the bill suggests a tension between patient safety regulation and provider operational flexibility.
HB 309 would substantially expand state oversight of office surgery practices by amending Florida’s physician and osteopathic office-surgery statutes. It would add mandatory annual inspections, JCAHO accreditation/conformance requirements, immediate suspension for refusal of inspection, an oversight committee, adverse-incident reporting rules, and a malpractice insurance or financial-responsibility minimum of $1 million. It would also impose detailed practice standards that limit which procedures may be performed in office settings and require specific staffing, anesthesia, equipment, and documentation safeguards, especially for gluteal fat grafting.
No committee discussion or vote history is provided, so there is no recorded legislative sentiment to summarize from debate or roll calls. From the bill text, the measure reads as a patient-safety and accountability bill, with a clear regulatory and enforcement-oriented approach. Its framing suggests support for stricter oversight of office surgeries, particularly after complications associated with cosmetic procedures, but the available record does not show whether lawmakers or stakeholders expressed support or opposition.
The likely areas of contention are the bill’s regulatory burden and cost implications for office-based surgeons, including annual inspections, JCAHO standards, staffing and equipment mandates, and the insurance requirement. The most specific controversy is likely around gluteal fat grafting restrictions, such as mandatory ultrasound guidance, one-to-one physician-to-patient ratios, and bans on intramuscular or submuscular injections. Physicians and office surgery operators may view these provisions as operationally restrictive, while patient-safety advocates would likely support them as necessary safeguards.